{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:12:02Z","timestamp":1777752722024,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109690","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:43:23Z","timestamp":1772095403000},"page":"109690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and pharmacological evaluation of phenylthiophene-2-carboxamide-based RSV fusion protein inhibitors"],"prefix":"10.1016","volume":"174","author":[{"given":"Muhammad Kashif","family":"Zaman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengming","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiubao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109690_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117282","article-title":"Unlocking the antiviral arsenal: structure-guided optimization of small-molecule inhibitors against RSV and hCoV-229E","volume":"291","author":"Karhan","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13052-025-01844-9","article-title":"Learn from international recommendations and experiences of countries that have successfully implemented monoclonal antibody prophylaxis for prevention of RSV infection","volume":"51","author":"Manti","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.bioorg.2026.109690_bb0015","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1021\/jm980239e","article-title":"Novel and specific respiratory syncytial virus inhibitors that target virus fusion","volume":"41","author":"Ding","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0020","article-title":"Discovery of a non-nucleoside inhibitor that binds to a novel site in the palm domain of the respiratory syncytial virus RNA-dependent RNA polymerase","volume":"99","author":"Kalin","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2026.109690_bb0025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ejmech.2017.07.032","article-title":"Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial virus (RSV) fusion inhibitors","volume":"138","author":"Feng","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0030","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1038\/s41467-024-46648-3","article-title":"Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus","volume":"15","author":"Lin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109690_bb0035","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(24)00138-7","article-title":"Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: A systematic review and meta-analysis of aggregated and individual participant data","volume":"403","author":"Wang","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bioorg.2026.109690_bb0040","series-title":"JAMA Pediatr.","first-page":"270","article-title":"Rates in bronchiolitis hospitalization, intensive care unit use, mortality, and costs from 2004 to 2018","volume":"176","author":"Mahant","year":"2022"},{"key":"10.1016\/j.bioorg.2026.109690_bb0045","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1021\/acs.jmedchem.1c00071","article-title":"Prodrugs of a 1k, rates in7, 9-dideazaadenosine C-nucleoside leading to the discovery of remdesivir (GS-5734) as a potent inhibitor of respiratory syncytial virus with efficacy in the African green monkey model of RSV","volume":"64","author":"Mackman","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13020097","article-title":"Development, current status, and remaining challenges for respiratory syncytial virus vaccines","volume":"13","author":"Anastassopoulou","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.bioorg.2026.109690_bb0055","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/acs.jmedchem.8b01361","article-title":"State of the art in respiratory syncytial virus drug discovery and development","volume":"62","author":"Cockerill","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0060","doi-asserted-by":"crossref","first-page":"11543","DOI":"10.1021\/acs.jmedchem.4c00630","article-title":"Recent Progress toward the discovery of Small molecules as novel anti-respiratory syncytial virus agents","volume":"67","author":"Felicetti","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/infdis\/jiad189","article-title":"Estimation of the number of respiratory syncytial virus-associated hospitalizations in adults in the European Union","volume":"228","author":"Osei-Yeboah","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.109690_bb0070","article-title":"Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses","volume":"15","author":"Wang","year":"2011","journal-title":"Health Technol. Assess. (Winchester, England)"},{"key":"10.1016\/j.bioorg.2026.109690_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/vaccines13020171","article-title":"Adherence to palivizumab for respiratory syncytial virus prophylaxis in Romanian infants","volume":"13","author":"Calomfirescu-Avramescu","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.bioorg.2026.109690_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14787210.2025.2481908","article-title":"Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children","volume":"23","author":"Carbonell-Estrany","year":"2025","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.bioorg.2026.109690_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2025.102639","article-title":"Efficacy of a standardized regional palivizumab administration protocol based on epidemic prediction for the following season","author":"Shimizu","year":"2025","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.bioorg.2026.109690_bb0090","doi-asserted-by":"crossref","first-page":"e250380","DOI":"10.1001\/jamanetworkopen.2025.0380","article-title":"Estimated effectiveness of nirsevimab against respiratory syncytial virus","volume":"8","author":"Xu","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bioorg.2026.109690_bb0095","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.6.2400046","article-title":"Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024","volume":"29","author":"L\u00f3pez-Lacort","year":"2024","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.bioorg.2026.109690_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1542\/hpeds.2024-008070","article-title":"Successful implementation of Nirsevimab and factors influencing uptake in neonatal care","volume":"15","author":"Puckett","year":"2025","journal-title":"Hosp. Pediatr."},{"key":"10.1016\/j.bioorg.2026.109690_bb0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1056\/NEJMoa2314885","article-title":"Nirsevimab and hospitalization for RSV bronchiolitis","volume":"391","author":"Assad","year":"2024","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bioorg.2026.109690_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113208","article-title":"Synthesis and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents","volume":"214","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0115","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/jm5017279","article-title":"Discovery of 4\u2032-chloromethyl-2\u2032-deoxy-3\u2032, 5\u2032-di-O-isobutyryl-2\u2032-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0120","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/jm070143x","article-title":"Selection of a respiratory syncytial virus fusion inhibitor clinical candidate, part 1: improving the pharmacokinetic profile using the structure\u2212 property relationship","volume":"50","author":"Bonfanti","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0125","series-title":"Respiratory Syncytial Virus Antivirals: Problems and Progress","first-page":"1417","author":"Hayden","year":"2020"},{"key":"10.1016\/j.bioorg.2026.109690_bb0130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/molecules29030598","article-title":"Prevention and potential treatment strategies for respiratory syncytial virus","volume":"29","author":"Sun","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109690_bb0135","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJM198306163082403","article-title":"Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study","volume":"308","author":"Hall","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bioorg.2026.109690_bb0140","series-title":"Discovery and Development of RSV604, Antiviral Drugs: from Basic Discovery Through Clinical Trials","first-page":"367","author":"Chapman","year":"2011"},{"key":"10.1016\/j.bioorg.2026.109690_bb0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1401184","article-title":"Oral GS-5806 activity in a respiratory syncytial virus challenge study","volume":"371","author":"DeVincenzo","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109690_bb0150","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1021\/acs.jmedchem.4c00514","article-title":"Spiro-azetidine oxindoles as long-acting injectables for pre-exposure prophylaxis against respiratory syncytial virus infections","volume":"67","author":"Kesteleyn","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0155","series-title":"C17. New Insights in Acute Pulmonary Infections, American Thoracic Society","first-page":"A4457","article-title":"A phase 2b, randomized, double-blind, placebo-controlled trial of presatovir (GS-5806), a novel oral RSV fusion inhibitor, for the treatment of respiratory syncytial virus (RSV) In Hospitalized Adults","volume":"197","author":"Hanfelt-Goade","year":"2018"},{"key":"10.1016\/j.bioorg.2026.109690_bb0160","doi-asserted-by":"crossref","first-page":"13723","DOI":"10.1021\/acs.jmedchem.4c00525","article-title":"Discovery of gem-dimethyl-hydroxymethylpyridine derivatives as potent non-nucleoside RSV polymerase inhibitors","volume":"67","author":"Grosse","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0165","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1093\/cid\/ciaa283","article-title":"Pharmacokinetics, safety, and antiviral effects of multiple doses of the respiratory syncytial virus (RSV) fusion protein inhibitor, JNJ-53718678, in infants hospitalized with RSV infection: a randomized phase 1b study","volume":"71","author":"Martin\u00f3n-Torres","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.109690_bb0170","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1021\/acs.jmedchem.2c00444","article-title":"Development of azaindole-based frameworks as potential antiviral agents and their future perspectives","volume":"65","author":"Urvashi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0175","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1021\/acs.jmedchem.0c01184","article-title":"JNJ-5371678, defining a role for fusion inhibitors in the treatment of respiratory syncytial virus","volume":"63","author":"Cockerill","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0180","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1021\/acs.jmedchem.0c00226","article-title":"Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl) propyl]-1 H-indol-2-yl} methyl)-1-(2, 2, 2-trifluoroethyl)-1, 3-dihydro-2 H-imidazo [4, 5-c] pyridin-2-one (JNJ-53718678), a potent and orally bioavailable fusion inhibitor of respiratory syncytial virus","volume":"63","author":"Vendeville","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0185","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1021\/acs.jmedchem.9b00654","article-title":"Discovery of ziresovir as a potent, selective, and orally bioavailable respiratory syncytial virus fusion protein inhibitor, in","volume":"62","author":"Zheng","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2352-4642(25)00067-7","article-title":"Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-up","volume":"9","author":"Zhang","year":"2025","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.bioorg.2026.109690_bb0195","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1021\/acs.jmedchem.4c02906","article-title":"DNA-encoded library screen identifies novel series of respiratory syncytial virus polymerase inhibitors","volume":"68","author":"Carney","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S2352-4642(25)00097-5","article-title":"Treatment for paediatric respiratory syncytial virus infection","volume":"9","author":"Sim\u00f5es","year":"2025","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.bioorg.2026.109690_bb0205","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acs.jmedchem.0c01882","article-title":"Discovery of Sisunatovir (RV521), an inhibitor of respiratory syncytial virus fusion","volume":"64","author":"Cockerill","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106325","article-title":"Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animal models","volume":"89","author":"Citron","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.bioorg.2026.109690_bb0215","article-title":"Current antiviral therapies and promising drug candidates against respiratory syncytial virus infection","volume":"64","author":"Feng","year":"2025","journal-title":"Virol. Sin."},{"key":"10.1016\/j.bioorg.2026.109690_bb0220","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01884-19","article-title":"A randomized, placebo-controlled, respiratory syncytial virus human challenge study of the antiviral efficacy, safety, and pharmacokinetics of RV521, an inhibitor of the RSV-F protein","volume":"64","author":"DeVincenzo","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.109690_bb0225","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1021\/acs.jmedchem.8b01394","article-title":"Discovery of benzoazepinequinoline (BAQ) derivatives as novel, potent, orally bioavailable respiratory syncytial virus fusion inhibitors","volume":"61","author":"Zheng","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0230","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/cid\/ciz1166","article-title":"A phase 2, randomized, double-blind, placebo-controlled trial of Presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients","volume":"71","author":"Chemaly","year":"2020","journal-title":"clinical infectious diseases : an official publication of the infectious diseases society of America"},{"key":"10.1016\/j.bioorg.2026.109690_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2025.102639","article-title":"Efficacy of a standardized regional palivizumab administration protocol based on epidemic prediction for the following season","volume":"31","author":"Shimizu","year":"2025","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.bioorg.2026.109690_bb0240","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2313551","article-title":"Ziresovir in hospitalized infants with respiratory syncytial virus infection","volume":"391","author":"Zhao","year":"2024","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.bioorg.2026.109690_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13176","article-title":"Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: a phase 2 proof-of-concept trial","volume":"17","author":"Huang","year":"2023","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.bioorg.2026.109690_bb0250","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/jm5017768","article-title":"Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study","volume":"58","author":"Mackman","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0255","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/AAC.48.2.413-422.2004","article-title":"Orally active fusion inhibitor of respiratory syncytial virus","volume":"48","author":"Cianci","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.109690_bb0260","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1128\/AAC.01497-15","article-title":"GS-5806 inhibits a broad range of respiratory syncytial virus clinical isolates by blocking the virus-cell fusion process","volume":"60","author":"Perron","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.109690_bb0265","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acs.jmedchem.0c01882","article-title":"Discovery of sisunatovir (RV521), an inhibitor of respiratory syncytial virus fusion","volume":"64","author":"Cockerill","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0270","doi-asserted-by":"crossref","first-page":"e747","DOI":"10.1016\/S1473-3099(24)00455-9","article-title":"The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access","volume":"24","author":"Terstappen","year":"2024","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.bioorg.2026.109690_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111861","article-title":"Design and synthesis of 2-((1H-indol-3-yl) thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus a","volume":"186","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0280","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/v15020341","article-title":"Biochemistry of the respiratory syncytial virus L protein embedding RNA polymerase and capping activities","volume":"15","author":"Sutto-Ortiz","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2026.109690_bb0285","series-title":"Encyclopedia of Virology (Third Edition)","first-page":"542","article-title":"Human respiratory syncytial virus","author":"Collins","year":"2008"},{"key":"10.1016\/j.bioorg.2026.109690_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106153","article-title":"Genomic evolution of human respiratory syncytial virus during a decade (2013\u22122023): bridging the path to monoclonal antibody surveillance","volume":"88","author":"Pi\u00f1ana","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.bioorg.2026.109690_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199483","article-title":"Biology of human respiratory syncytial virus: current perspectives in immune response and mechanisms against the virus","volume":"350","author":"Girma","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.bioorg.2026.109690_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319437","article-title":"Microevolution and phylogenomic study of respiratory syncytial virus type a","volume":"20","author":"Ahmad","year":"2025","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2026.109690_bb0305","doi-asserted-by":"crossref","first-page":"18949","DOI":"10.1021\/acs.jmedchem.5c00692","article-title":"Discovery of tricyclic derivative as novel and potent respiratory syncytial virus fusion glycoprotein inhibitor with an improved pharmacokinetic profile","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0310","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.1021\/acs.jmedchem.4c00899","article-title":"Discovery of GS-7682, a novel 4\u2032-cyano-modified C-nucleoside prodrug with broad activity against pneumo-and picornaviruses and efficacy in RSV-infected African green monkeys","volume":"67","author":"Siegel","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0315","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/jm5017768","article-title":"Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study, in","volume":"58","author":"Mackman","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0320","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejmech.2017.04.070","article-title":"Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus","volume":"135","author":"Tonelli","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0325","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nchembio.1982","article-title":"Molecular mechanism of respiratory syncytial virus fusion inhibitors","volume":"12","author":"Battles","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109690_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115799","article-title":"Design, synthesis, and anti-respiratory syncytial virus potential of novel 3-(1, 2, 3-triazol-1-yl) furoxazine-fused benzimidazole derivatives","volume":"261","author":"Mao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nchembio.1982","article-title":"Molecular mechanism of respiratory syncytial virus fusion inhibitors","volume":"12","author":"Battles","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109690_bb0340","article-title":"Advances in development of antiviral strategies against respiratory syncytial virus","author":"Yang","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.bioorg.2026.109690_bb0345","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among US FDA approved pharmaceuticals: miniperspective","volume":"57","author":"Vitaku","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0350","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.apsb.2022.09.010","article-title":"Benzimidazole and its derivatives as cancer therapeutics: the potential role from traditional to precision medicine","volume":"13","author":"Lee","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2026.109690_bb0355","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1021\/acsmedchemlett.4c00473","article-title":"Novel substituted benzimidazole compounds as TLR9 inhibitors for treating fibrotic diseases, particularly idiopathic pulmonary fibrosis, in","author":"Sabnis","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109690_bb0360","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/acs.jmedchem.9b01809","article-title":"Discovery of highly potent benzimidazole derivatives as indoleamine 2, 3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity","volume":"63","author":"Serafini","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137940","article-title":"Design, synthesis and computational study of benzimidazole derivatives as potential anti-SARS-CoV-2 agents","volume":"1306","author":"Ananta","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109690_bb0370","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.3390\/ijms26146823","article-title":"Novel compounds featuring a thiophene carboxamide scaffold: synthesis, characterization and antiproliferative evaluation","volume":"26","author":"Mara","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109690_bb0375","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13065-018-0511-5","article-title":"Therapeutic importance of synthetic thiophene","volume":"12","author":"Shah","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2026.109690_bb0380","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13065-023-00917-2","article-title":"Synthesis, DFT investigations, antioxidant, antibacterial activity and SAR-study of novel thiophene-2-carboxamide derivatives","volume":"17","author":"Metwally","year":"2023","journal-title":"BMC Chemistry"},{"key":"10.1016\/j.bioorg.2026.109690_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202305002","article-title":"Recent Progress in transformations of azepine\/Oxazepine\/thiazepine derivatives","volume":"9","author":"Doraghi","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109690_bb0390","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3762\/bjoc.20.241","article-title":"Synthesis of pyrrole-fused dibenzoxazepine\/dibenzothiazepine\/triazolobenzodiazepine derivatives via isocyanide-based multicomponent reactions","volume":"20","author":"Norouzi","year":"2024","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0395","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s10593-021-02917-3","article-title":"Recent advances on heterocyclic compounds with antiviral properties","volume":"57","author":"De","year":"2021","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.bioorg.2026.109690_bb0400","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/irv.12503","article-title":"The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin","volume":"11","author":"Kim","year":"2017","journal-title":"Influenza Other Respi. Viruses"},{"key":"10.1016\/j.bioorg.2026.109690_bb0405","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.17.5.770","article-title":"Effects of ribavirin on respiratory syncytial virus in vitro","volume":"17","author":"Hruska","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.109690_bb0410","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/tx9601622","article-title":"Thiophene sulfoxides as reactive metabolites: formation upon microsomal oxidation of a 3-aroylthiophene and fate in the presence of nucleophiles in vitro and in vivo","volume":"9","author":"Valadon","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2026.109690_bb0415","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1021\/acs.chemrestox.5b00364","article-title":"Toxicity originating from thiophene containing drugs: exploring the mechanism using quantum chemical methods","volume":"28","author":"Jaladanki","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2026.109690_bb0420","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/C9MD00396G","article-title":"Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds","volume":"11","author":"Lazzara","year":"2020","journal-title":"RSC Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2026.109690_bb0425","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1021\/acs.orglett.3c00685","article-title":"Relay organophotoredox\/N-heterocyclic carbene catalysis-enabled asymmetric synthesis of Dibenzoxazepine-fused pyrrolidinones","volume":"25","author":"Hussain","year":"2023","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2026.109690_bb0430","doi-asserted-by":"crossref","first-page":"15761","DOI":"10.1021\/acs.joc.3c01800","article-title":"Photocatalytic cross-coupling of Tetrafluoropyridine Sulfides with vinyl halides for the synthesis of \u03b2, \u03b3-unsaturated carbonyl compounds","volume":"88","author":"Zaman","year":"2023","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.109690_bb0435","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1055\/a-2102-7006","article-title":"Decarboxylative oxidation of carboxylic acids using photocatalysis and copper catalysis","volume":"34","author":"Zaman","year":"2023","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2026.109690_bb0440","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:00:50Z","timestamp":1777464050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":88,"alternative-id":["S0045206826002269"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109690","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and pharmacological evaluation of phenylthiophene-2-carboxamide-based RSV fusion protein inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109690"}}